FULC - Fulcrum Therapeutics GAAP EPS of -$0.39 beats by $0.04 revenue of $0.76M misses by $0.29M
2023-11-07 07:16:01 ET
More on Fulcrum Therapeutics
- An Updated View On Fulcrum Therapeutics
- Fulcrum's Balance: Between Promise And Uncertainty
- Fulcrum upgraded to buy at Stifel on ending of clinical hold
- Biggest stock movers today: Macy's, DICK'S Sporting Goods, Canadian Solar and more
- Seeking Alpha’s Quant Rating on Fulcrum Therapeutics
For further details see:
Fulcrum Therapeutics GAAP EPS of -$0.39 beats by $0.04, revenue of $0.76M misses by $0.29M